The risky business of cell culture
07 October, 2015 by Lauren DavisThe process of cell culture is one which can be beneficial for modelling health and disease but is not without its risks — risks which many scientists are often willing to take.
Governments shouldn't be able to censor research results they don't like
20 July, 2015 by Kypros Kypri, University of NewcastleGovernments often impose legal conditions on such research that can subvert science and the public interest.
Global chemical classification system coming to Australia
20 April, 2015The United Nations has updated the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - an internationally agreed system that aims to synchronise chemical labelling in order to optimise safety.
Scientists said to be tweaking their experiments
23 March, 2015 by Lauren DavisAustralian researchers have stated that some scientists are unknowingly tweaking experiments and analysis methods in order to increase their chances of obtaining easily publishable results.
Australian IP system simplified
11 February, 2015The Australian Government's Intellectual Property Laws Amendment Act 2015, which passed the Senate this week, introduces changes which are said to simplify aspects of Australia's intellectual property (IP) system.
Ethical guidelines on organ transplantation open for consultation
19 January, 2015The National Health and Medical Research Council (MHMRC) has released a draft document to inform decisions around the allocation of organs for transplantation.
Ethical guidelines on organ transplantation open for consultation
19 January, 2015The National Health and Medical Research Council (NHMRC) has released a draft document to inform decisions around the allocation of organs for transplantation.
No more ANZ therapeutic products regulator
21 November, 2014The Australian and New Zealand governments have ceased efforts to establish a joint therapeutic products regulator, the Australia New Zealand Therapeutic Products Agency (ANZTPA).
TGA joins international collaboration to evaluate generic drugs
03 September, 2014The Therapeutic Good Administration (TGA) has joined a pilot of the Decentralised Procedure (DCP) of the European Union - a collaboration on the evaluation of generic drug applications.
European cancer research could be at risk
31 July, 2014The European Society For Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.
The debate on criminalising research fraud
18 July, 2014 by Lauren DavisThe BMJ has featured an article in which two experts go head to head discussing the potential criminalisation of research fraud.
Supreme Court decision upholds farmers' right to coexistence
30 May, 2014 by Lauren DavisThe Supreme Court of Western Australia has dismissed an organic farmer's claims for $85,000 in damages over contamination from his neighbour's genetically modified (GM) canola crop.
Qiagen products cleared by FDA
08 May, 2014The US FDA has cleared the Qiagen artus C. difficile QS-RGQ MDx Kit to qualitatively detect Clostridium difficile, a widespread healthcare-associated infection. The test was developed in partnership with IntelligentMDx and CE marked in December 2013.
Public comment sought on ethical guidelines of assisted reproductive technology
14 March, 2014The National Health and Medical Research Council's (NHMRC) Australian Health Ethics Committee (AHEC) is conducting a review of Part B (the clinical practice section) of the Ethical Guidelines on the Use of Assisted Reproductive Technology in Clinical Practice and Research, 2007.
Review to reduce red tape for universities
05 August, 2013The Australian Government today released a major review examining how red tape can be reduced for universities while also supporting the quality and excellence of Australia’s world-class university system.
